Skip to main content

Technology & AI

OpenAI partners with Novo Nordisk to accelerate drug discovery and delivery

By Mike Wheatley Source: SiliconANGLE News
OpenAI partners with Novo Nordisk to accelerate drug discovery and delivery

OpenAI has partnered with pharmaceutical company Novo Nordisk to leverage artificial intelligence in accelerating drug discovery and delivery processes. The collaboration aims to apply OpenAI's AI capabilities to advance pharmaceutical research and development within the industry. Financial terms of the partnership were not disclosed in the announcement.

Read Full Article at SiliconANGLE News

Related Articles